Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211
| Image |  |
|---|---|
| Description | scientific article published on 05 June 2007 |
| Author/s |
author: Daniel Kuritzkes Roy M Gulick |
| Publication date | June 5, 2007 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |